SEC Form 3 · accession 0001209191-18-052303

Ra Medical Systems, Inc. · VTAK

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — CFO & Secretary

Period of report

Sep 26, 2018

Accepted (ET)

Sep 26, 2018 · 4:51 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001716621

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	holding	—	—		—	39,482	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F2	$28.94	holding	—	—	—	—	Jun 4, 2028	Common Stock	290,000	—	D

F1Reported shares are represented by restricted stock units ("RSUs"), and each RSU is the economic equivalent of one share of Ra Medical Systems, Inc. common stock. Thirty-three percent (33%) of the RSUs shall vest on the 10th day of the third month following the expiration of the Lock-Up Period (as defined in the award agreement), thirty-three percent (33%) of the RSUs shall vest on the 15th day of the sixth month following the expiration of the Lock-Up Period, and thirty-four percent (34%) of the RSUs shall vest on the 20th day of the ninth month following the expiration of the Lock-Up Period, subject to continued service. In the event of a Change in Control (as defined in the Issuer's 2018 Stock Compensation Plan), one-hundred percent (100%) of the RSUs shall immediately become fully vested, subject to the reporting persons continued service.
F2One-third of the shares subject to the option shall vest on June 4, 2019, and one thirty-sixth of the shares subject to the option shall vest monthly thereafter, subject to the reporting person's continued service. If the reporting person's employment with the Company is terminated by the Company without cause, one-hundred percent (100%) of the shares subject to the option that have not vested shall immediately vest.

Exhibit 24 - Power of Attorney